Viewing Study NCT04896632


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2025-12-30 @ 12:50 PM
Study NCT ID: NCT04896632
Status: TERMINATED
Last Update Posted: 2023-09-28
First Post: 2021-05-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-05-13
Start Date Type: ACTUAL
Primary Completion Date: 2022-11-24
Primary Completion Date Type: ACTUAL
Completion Date: 2022-11-24
Completion Date Type: ACTUAL
First Submit Date: 2021-05-12
First Submit QC Date: None
Study First Post Date: 2021-05-21
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-09-26
Last Update Post Date: 2023-09-28
Last Update Post Date Type: ACTUAL